Cocrystal Pharma Files 8-K on Aug 19 Events
Ticker: COCP · Form: 8-K · Filed: Aug 20, 2024 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | Aug 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: COCP
TL;DR
Cocrystal Pharma (COCP) filed an 8-K on Aug 20 for Aug 19 events - check financials & Reg FD updates.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on August 20, 2024, reporting events as of August 19, 2024. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc., is incorporated in Delaware and headquartered in Bothell, WA.
Why It Matters
This 8-K filing provides updates on Cocrystal Pharma's regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating immediate significant financial or operational changes.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- August 19, 2024 (date) — Earliest event date
- August 20, 2024 (date) — Filing date
- BIOZONE PHARMACEUTICALS, INC. (company) — Former company name
- International Surf Resorts, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Bothell, WA (location) — Principal executive office location
FAQ
What specific events are being disclosed under Regulation FD as of August 19, 2024?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What financial statements and exhibits are included in this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in the provided text.
When was Cocrystal Pharma, Inc. previously known as BIOZONE PHARMACEUTICALS, INC.?
The date of name change from BIOZONE PHARMACEUTICALS, INC. to Cocrystal Pharma, Inc. is not specified in the provided text, only that it was a former name.
What is the Commission File Number for Cocrystal Pharma, Inc.?
The Commission File Number for Cocrystal Pharma, Inc. is 001-38418.
What is the IRS Employer Identification Number for Cocrystal Pharma, Inc.?
The IRS Employer Identification Number for Cocrystal Pharma, Inc. is 35-2528215.
Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2024-08-20 08:00:14
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 20KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001493152-24-033220.txt ( ) — 244KB
- cocp-20240819.xsd (EX-101.SCH) — 3KB
- cocp-20240819_lab.xml (EX-101.LAB) — 33KB
- cocp-20240819_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 20, 2024 Cocrystal Pharma, Inc. By: /s/ James Martin Name: James Martin Title: Chief Financial Officer and Co-Chief Executive Officer